Australia - Inggris - Department of Health (Therapeutic Goods Administration)

amneal pharma australia pty ltd - roxithromycin -

Australia - Inggris - Department of Health (Therapeutic Goods Administration)

amneal pharma australia pty ltd - roxithromycin -

Australia - Inggris - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - roxithromycin, quantity: 300 mg - tablet, film coated - excipient ingredients: povidone; hyprolose; maize starch; poloxamer; colloidal anhydrous silica; purified talc; magnesium stearate; glucose; titanium dioxide; hypromellose; propylene glycol - adults: roxithromycin is indicated for the treatment of the following types of mild to moderately severe infections in adults caused by or likely to be caused by susceptible micro-organisms: upper respiratory tract infection: acute pharyngitis, tonsillitis, and sinusitis. lower respiratory tract infection: acute bronchitis and acute exacerbation of chronic bronchitis; community acquired pneumonia. skin and skin structure infections. non-gonococcal urethritis. children: roxithromycin 150 mg tablets are indicated for the treatment of the following mild to moderately severe infections in children weighing greater than 40 kg caused by or likely to be caused by susceptible micro-organisms: acute pharyngitis. acute tonsillitis. impetigo. appropriate culture and sensitivity tests should be performed when necessary to determine an organisms susceptibility and thus treatment suitability. therapy with roxithromycin may be initiated before results of these tests are known; once results become available, appropriate therapy should be continued.

Selandia Baru - Inggris - Medsafe (Medicines Safety Authority)

teva pharma (new zealand) limited - roxithromycin 300mg;   - coated tablet - 300 mg - active: roxithromycin 300mg   excipient: colloidal silicon dioxide glucose hyprolose hypromellose magnesium stearate maize starch povidone propylene glycol purified talc titanium dioxide water

Malaysia - Inggris - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

imeks pharma sdn. bhd. - roxithromycin -

Selandia Baru - Inggris - Medsafe (Medicines Safety Authority)

viatris limited - roxithromycin 150mg (based on 100% assay - maize starch quantity will be adjusted); roxithromycin 150mg (based on 100% assay - maize starch quantity will be adjusted) - film coated tablet - 150 mg - active: roxithromycin 150mg (based on 100% assay - maize starch quantity will be adjusted) excipient: colloidal silicon dioxide glucose hyprolose magnesium stearate maize starch opadry white oy-s-58918 poloxamer 188 povidone purified talc purified water   active: roxithromycin 150mg (based on 100% assay - maize starch quantity will be adjusted) excipient: colloidal silicon dioxide glucose hyprolose magnesium stearate maize starch opadry white oy-s-58918 poloxamer 188 povidone purified talc purified water  

Selandia Baru - Inggris - Medsafe (Medicines Safety Authority)

sanofi-aventis new zealand limited - roxithromycin 150mg - film coated tablet - 150 mg - active: roxithromycin 150mg excipient: colloidal silicon dioxide glucose hypromellose   magnesium stearate maize starch poloxamer povidone propylene glycol purified talc titanium dioxide

Yordania - Inggris - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

شركة دار الدواء للتنمية والأستثمار - dar al dawa development and investment co ltd - roxithromycin 150 mg - 150 mg

Yordania - Inggris - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

شركة دار الدواء للتنمية والأستثمار - dar al dawa development and investment co ltd - roxithromycin 150 mg - 150 mg

Yordania - Inggris - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

الشركة الدولية للدواء - pharma international company - roxithromycin 150 mg - 150 mg